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This study estimated excess home healthcare use and expenditures among elderly Medicare beneficiaries (age ≥ 65 years) with
Parkinson’s disease (PD) compared to those without PD and analyzed the extent to which predisposing, enabling, need factors,
personal health choice, and external environment contribute to the excess home healthcare use and expenditures among individuals
with PD. A retrospective, observational, cohort study design using Medicare 5% sample claims for years 2006-2007 was used for
this study. Logistic regressions and Ordinary Least Squares regressions were used to assess the association of PD with home health
use and expenditures, respectively. Postregression nonlinear and linear decomposition techniques were used to understand the
extent to which differences in home healthcare use and expenditures among elderly Medicare beneficiaries with and without PD
can be explained by individual-level factors. Elderly Medicare beneficiaries with PD had higher home health use and expenditures
compared to those without PD. 27.5% and 18% of the gap in home health use and expenditures, respectively, were explained by
differences in characteristics between the PD and no PD groups. A large portion of the differences in home healthcare use and
expenditures remained unexplained.
1. Introduction
Elderly individuals with PD experience substantially higher
healthcare expenditures compared to those without PD [1–
4]. Specifically, home healthcare expenditures have been
observed to be consistently and substantially higher among
elderly individuals with PD compared to those without PD
[1–4]. The magnitude of the difference in home healthcare
expenditure varies depending on study population as well
as the year in which the studies were conducted. Existing
literature suggests that in the United States (US) the average
annual home healthcare expenditures among elderly individ-
uals with PD can be as high as 3.2 times more compared
to those without PD [2]. Home healthcare use has also
been shown to be higher among elderly individuals with PD
compared to those without PD. Rates of home healthcare
use have been observed to vary from twofold [1, 3] to more
than threefold [2] higher among elderly individuals with PD
compared to those without PD in the USA.
As PD has higher prevalence among elderly individuals
(≥65 years) than among other age groups, most of the elderly
living in the United States (US) are eligible for Medicare.
Therefore, most of home healthcare spending will be borne
by Medicare. It has been estimated that total Medicare home
healthcare expenditures increased from $8.5 billion in 2000
to $18 billion in 2012, a 112% increase [5]. Because of the
accelerated growth of home healthcare expenditures the
Centers for Medicare and Medicaid Services (CMS) agency
has been exploringways to reduce the excess home healthcare
expenditures.Thus, an understanding of factors contributing
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to home healthcare among all the elderly and specifically
those with PD who are high utilizers of home healthcare is
critical. However, to the best of authors’ knowledge, no study
has analyzed various factors associated with higher home
healthcare use and expenditures among individuals with PD.
Therefore, the aims of this study were to (i) estimate excess
home healthcare use and expenditures associated with PD,
(ii) examine factors associated with excess home healthcare
use and expenditures, and (iii) quantify the extent to which
each of the different sets of factors explains excess home
healthcare use and expenditures among individuals with PD
compared to those without PD.
2. Methods
2.1. Conceptual Framework. The conceptual behavioral
model by Andersen was used to examine the predisposing,
enabling, need, personal health choices, and external
environmental factors associated with the healthcare
expenditures [6]. The Andersen Behavioral Model (ABM)
has been used in various studies related to usage of health
services (both healthcare use and expenditures). The ABM
posits an individual’s use of health services as a function of
(1) predisposing, (2) enabling, (3) need factors, (4) personal
health choices, and (5) external environment.The individual’s
characteristics that are predisposing include demographic
characteristics (e.g., gender, age, and race/ethnicity). The
ability of an individual to access a health service is termed as
an enabling factor (e.g., public assistance). Need factors are
represented either by a subjective acknowledgement of need
such as a patient’s symptoms or by a professional’s judgment
of the need for healthcare based on disease characteristics
(e.g., number of comorbidities). Personal health choices (e.g.,
substance use) and external environment characteristics (e.g.,
census region, metro status) also influence an individual’s
use of health services.
2.1.1. Study Design. We used a retrospective, observational,
cohort study design with 12-month baseline and 12-month
follow-up period. For the purposes of this study, Medicare
5% sample claims database for years 2006-2007 was used.
Calendar year 2006was considered as the baseline period and
calendar year 2007 was considered as the follow-up period.
2.1.2. Data Source. The data were derived from the Medicare
5% sample, which contains all final action claims data for a
random 5% sample of all claims ofMedicare beneficiaries [7].
Available standard analytic files (SAF) inMedicare 5% sample
claims database are (1) inpatient, (2) outpatient (encom-
passing claims from physician office), (3) skilled nursing
facility, (4) carrier, (5) hospice care, (6) home health, and (7)
durable medical equipment analytic data files. The Medicare
5% sample claims database can be used to conduct both cross-
sectional and longitudinal studies. A unique, deidentified
Medicare beneficiary identifier is assigned to each enrollee,
which is used to follow them longitudinally. Several studies
have been conducted using this database [8–10].The informa-
tion recorded in the claims dataset includes dates of service
provided, charge and payment amounts, clinical diagnosis
codes, and procedure codes. Information on demographic
characteristics such as age, gender, and race/ethnicity is
available in the denominator files of Medicare claims dataset.
The home healthcare files consist of fee-for-service claims
for Medicare-certified home health services, service dates,
claim payment amount, primary diagnosis code (ICD-9-CM
codes), up to 9 other diagnosis codes, and the total number
of home healthcare visits.
Study Sample. Our study sample comprised community-
dwelling elderly Medicare beneficiaries aged 65 years and
older, who were alive and had continuous Part A and Part
B enrollment during 2006 and 2007. Medicare beneficiaries
enrolled in Health Maintenance Organizations (HMO) were
excluded due to unavailability ofHMOclaims. To be included
in the final study sample, individuals with and without PD
were required to have positive direct healthcare expenditures.
Individuals with end-stage renal disease (ESRD) were also
excluded from the final sample. The final sample size was
60,874with 10,865 elderlyMedicare beneficiarieswith PDand
50,009 elderlyMedicare beneficiaries without PD.The cohort
development of this study is shown in Figure 1.
2.1.3. Measures
Dependent Variable
Home Healthcare Use. Home healthcare use was identified
during the follow-up period (i.e., calendar year 2007). Elderly
Medicare beneficiaries with any paid home healthcare visit
during the follow-up period were considered to be home
health users.
HomeHealthcare Expenditures. Among users of home health-
care, we examined home healthcare expenditures during
follow-up period (i.e., calendar year 2007). We used actual
Medicare payments to calculate home healthcare expendi-
tures from home healthcare file. Home health expenditure
was skewed to the right and, therefore, we transformed
expenditures with natural logarithm.
2.2. Key Independent Variable: PD and No PD. Presence or
absence of PD constituted the key independent variable for
this study and this was measured during baseline period.
Individuals with PD were identified using International
Classification of Diseases, Ninth Revision, Clinical Modifica-
tion (ICD-9-CM) codes of 332.xx. Use of ICD-9-CM codes
from Medicare claims to identify PD has modest sensitivity
(61.13%) and positive predictive value (65.13%) and the very
high specificity (99.08%) [11].
2.3. Independent Variables. All independent variables were
measured during the baseline period. The predisposing char-
acteristics comprised gender (women/men), race/ethnicity
(white, African American, Latino, and others), and age (65–
74 and 75 years and older). Enabling characteristics con-
sisted of public assistance (which was indicated by Medicare
premiums and deductibles that were subsidized by the state
keeping in view the financial status of the enrollee). The
need factors comprised the number of other cooccurring
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Total Medicare beneficiaries in 2006:
1,937,742
Total Medicare beneficiaries meeting 
study inclusion criteria in 2006:
1,160,353
Parkinson’s disease identified 
in 2006 using ICD-9-CM code of
332.xx
Random 5% sample from no PD 
population
Inclusion criteria (2007)
(ii) Age, gender, race nonmissing
(iii) Full year Part A and B coverage 
(iv) No HMO coverage
(v) Not dying in 2007
(vi) No ESRD 
(i) Age ≥ 65 years
Inclusion criteria (2006)
(ii) Age, gender nonmissing
(iii) Full year Part A and B coverage
(iv) No HMO coverage
(v) Not dying in 2006
(vi) No ESRD
(i) Age ≥ 65 years
PD (N) = 13,275
No PD (N) = 1,147,078
Sample meeting all criteria
PD (N) = 10,865
No PD (N) = 997,785
Final study sample
PD (N) = 10,865
No PD (N) = 50,009
Figure 1: Cohort development.
comorbidities. Personal health choices consisted of substance
use disorders that included alcohol, tobacco, and drug use.
This domain also included baseline healthcare use. The
external environment factors comprised census region and
metro status.
2.3.1. Statistical Methods. Statistically significant differences
in home healthcare use during follow-up period by presence
of PD were ascertained with chi-square tests. Logistic regres-
sions were used to examine the association between home
healthcare use and PD after controlling for predisposing,
enabling, need factors, personal health choices, and external
environment.
We examined the differences in average home healthcare
expenditures between PD and no PD groups by using 𝑡-tests.
We also conductedOrdinary Least Squares (OLS) regressions
on log-transformed home healthcare expenditures during
follow-up period to examine the relationship between PD
and home healthcare expenditures after controlling for pre-
disposing, enabling, need factors, personal health choices,
and external environment. The relationship between home
healthcare use and expenditures for each characteristic was
ascertained by using chi-square tests and 𝑡-tests for every
characteristic between PD and no PD groups.
Postregression Decomposition Techniques. To assess the extent
to which differences in home healthcare use and expenditures
among individuals with and without PD can be explained by
predisposing, enabling, need factors, personal health choices,
and external environmental factors, we used postregression
decomposition techniques. The differences in home health-
care use or expenditures between the two groups of individ-
uals with and without PD are compartmentalized into two
parts: (1) one part is attributable to the differences in charac-
teristics, which is the explained portion of the differences, and
(2) the other part is the differences attributable to differences
in coefficients. The explained portion of the gap is the sum of
the differences between individuals with and without PD in
terms of the observed or measured characteristics weighted
by the estimated coefficients of individuals with PD.
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For home healthcare expenditures, we used postregres-
sion linear decomposition [12, 13]. For home healthcare use,
a postregression nonlinear decomposition was used because
home healthcare use was measured as a binary variable [14].
In the nonlinear decomposition, the contribution of each
of the individual-level factors to the gap in terms of home
healthcare use between the two groups is estimated by the
change in the mean predicted probability by superimposing
the distribution of elderly Medicare beneficiaries with PD
on those without PD, keeping all other factors constant
[14].
A common problem encountered with decomposition
techniques is the “index number” problem. As the char-
acteristics can be weighted by the regression coefficients
from PD group or no PD group, the estimates of explained
portion will vary. Many solutions have been proposed to
overcome this problem [15–18]. For the current study we used
the solution proposed by Neumark and used the estimated
regression coefficients from a regression combining PD and
no PD group in which presence of PD was not used as an
independent variable [15].
Analyses were conducted using SAS version 9.3 (SAS
Institute Inc., Cary, NC). STATA version 13.0 was used to
perform nonlinear decomposition, whereas Blinder-Oaxaca
linear decomposition was performed using Microsoft Excel
2013.
3. Results
Table 1 describes the study sample overall as well as by PD
status. The final study sample consisted of 60,874 elderly
Medicare beneficiaries among whom 10,865 had PD and
50,009 did not have PD. Overall, the majority of the study
participants comprised women (58.3%) and whites (89.8%)
and were 75 years and older (51.2%). The average number of
comorbidities in the overall study sample was 17.26 (±10.38).
In terms of predisposing, enabling, need, personal health
choice, and external environmental factors, all the char-
acteristics were statistically significantly different between
elderlyMedicare beneficiarieswith andwithout PD except for
baseline substance use disorder and cancer. Among elderly
Medicare beneficiaries with PD, a higher percentage were
men (50.1%) and among those without PD a significantly
lower percentage were men (39.9%). A greater proportion
of elderly Medicare beneficiaries with PD were 75 years and
older (63.9%) and a lower proportion of elderly Medicare
beneficiaries without PD were 75 years and older (48.4%).
The study sample consisted of an overwhelming majority of
whites in both the groups (around 90% in both groups). A
higher percentage of elderly Medicare beneficiaries were on
public assistance among those with PD (16.0%) compared
to those without PD (11.4%). Elderly Medicare beneficiaries
with PD (21.97 ± 11.75) had a significantly higher number of
comorbidities compared to those without PD (16.24 ± 9.76).
Elderly Medicare beneficiaries with PD had significantly
higher rates of baseline inpatient, outpatient, hospice, skilled
nursing facilities, and durable medical equipment use. An
overwhelmingly higher percentage of elderly Medicare bene-
ficiaries resided in the metro regions in both the two groups
(approximately 80% in both groups). Elderly Medicare ben-
eficiaries in both PD and no PD groups resided primarily
in the Southern census region (around 38% in both groups)
followed by Midwest, Northeastern, and Western regions.
Table 2 exhibits the relationship between predisposing,
enabling, personal health choice, need, and external environ-
mental factors and home healthcare use and average home
healthcare expenditure by PD status. There were 2,445 and
4,061 elderly Medicare beneficiaries with and without PD,
respectively, who had home healthcare use. Overall, 22.5%
of the elderly with PD used home healthcare compared
to 9.2% without PD (𝑝 < .001). This translated into a
13.3-percentage-point difference in home healthcare use. For
every characteristic (except for elderlyMedicare beneficiaries
with skilled nursing facility visits), home healthcare use
was higher among the elderly with PD compared to those
without PD (Table 2). For example, the home healthcare
use among women (24.9% versus 10.5%) and men (20.2%
versus 7.3%) with PD was significantly higher compared to
those without PD. Table 2 also summarizes the average home
healthcare expenditures among home healthcare users by the
presence or absence of PD. The average home healthcare
expenditures among elderly Medicare beneficiaries (who
used home healthcare service) with PDwere 1.37 times higher
compared to those without PD ($6,792 versus $4,965). Home
healthcare expenditures were also significantly higher across
each characteristic among the elderly with PD compared to
those without PD. For example, average home healthcare
expenditures among women ($7,055 versus $5,201) and men
($6,469 versus $4,453) with PD were significantly higher
compared to those without PD.
Table 3 summarizes the findings from the logistic regres-
sion analyses of home healthcare use and OLS regressions
analyses on log-transformed home healthcare expenditures
on a pooled sample among elderly Medicare beneficiaries
who had used home healthcare. It was observed that, after
controlling for predisposing, enabling, need, personal health
choice, and external environmental factors, elderly individ-
uals with PD were more than two times (Adjusted Odds
Ratio: 2.12; 95% Confidence Interval: 1.99–2.25) as likely to
have home healthcare use as those without PD. It can be
noted from theOLS regression analyses that elderlyMedicare
beneficiaries with PD had 39% (calculated using the formula
exp(𝛽) − 1) higher home healthcare expenditure compared to
those without PD.
Table 4 summarizes the results from the nonlinear and
linear decomposition on the home healthcare use (yes/no)
and expenditures. There was a 13.3-percentage-point differ-
ence in home healthcare use between these two groups in
terms of home healthcare use. From the multivariate decom-
position analysis, it was observed that, out of the 13.3-per-
centage-point difference in home healthcare use among eld-
erly Medicare beneficiaries, a 3.64-percentage-point differ-
ence was explained by the individual-level variables included
in this study. Thus, a 27.5% difference in home healthcare use
among elderly Medicare beneficiaries with and without PD
was explained by the predisposing, enabling, need, personal
health choice, and external environmental factors. Need
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Table 1: Description of study sample, overall and by Parkinson’s disease status among Medicare beneficiaries. National Medicare 5% sample,
2006-2007.
Variables Overall Col.% PD Col.% No PD Col.% Sig.
𝑁 = 60,874 𝑁 = 10,865 𝑁 = 50,009
Predisposing characteristics
Gender ∗∗∗
Female 35,470 58.3 5,421 49.9 30,049 60.1
Male 25,404 41.7 5,444 50.1 19,960 39.9
Race/ethnicity ∗∗∗
White 54,652 89.8 10,007 92.1 44,645 89.3
AA 3,695 6.1 425 3.9 3,270 6.5
Others 2,527 4.2 433 4.0 2,094 4.2
Age group ∗∗∗
65–74 29,725 48.8 3,927 36.1 25,798 51.6
75, + 31,149 51.2 6,938 63.9 24,211 48.4
Enabling characteristics
Public assistance ∗∗∗
Yes 7,445 12.2 1,742 16.0 5,703 11.4
No 53,429 87.8 9,123 84.0 44,306 88.6
External environmental characteristics
Census region ∗∗∗
Northeastern 11,983 19.7 2,399 22.1 9,584 19.2
Midwest 15,842 26.0 2,837 26.1 13,005 26.0
South 23,323 38.3 3,931 36.2 19,392 38.8
West 9,726 16.0 1,698 15.6 8,028 16.1
Metro status ∗∗∗
Metro 46,162 75.8 8,448 77.8 37,714 75.4
No metro 14,712 24.2 2,417 22.2 12,295 24.6
Personal health practices
Substance use
Yes 2,337 3.8 440 4.0 1,897 3.8
No 58,537 96.2 10,425 96.0 48,112 96.2
Inpatient visit ∗∗∗
Yes 12,875 21.2 3,584 33.0 9,291 18.6
No 47,999 78.8 7,281 67.0 40,718 81.4
DME visit ∗∗∗
Yes 19,239 31.6 4,679 43.1 14,560 29.1
No 41,635 68.4 6,186 56.9 35,449 70.9
Hospice visit ∗∗∗
Yes 256 0.4 122 1.1 134 0.3
No 60,618 99.6 10,743 98.9 49,875 99.7
SNF visit ∗∗∗
Yes 3,576 5.9 1,597 14.7 1,979 4.0
No 57,298 94.1 9,268 85.3 48,030 96.0
Outpatient visit quintile ∗∗∗
0-0 14,403 23.7 1,708 15.7 12,695 25.4
1-1 10,153 16.7 1,469 13.5 8,684 17.4
2-3 13,303 21.9 2,306 21.2 10,997 22.0
4–6 10,654 17.5 2,234 20.6 8,420 16.8
7–178 12,361 20.3 3,148 29.0 9,213 18.4
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Table 1: Continued.
Variables Overall Col.% PD Col.% No PD Col.% Sig.
𝑁 = 60,874 𝑁 = 10,865 𝑁 = 50,009
Office visit quintile ∗∗∗
0–5 9,433 15.5 502 4.6 8,931 17.9
6–10 12,697 20.9 1,335 12.3 11,362 22.7
11–16 12,676 20.8 2,082 19.2 10,594 21.2
17–25 12,058 19.8 2,632 24.2 9,426 18.8
26–281 14,010 23.0 4,314 39.7 9,696 19.4
Need factor
Average S.D. Average S.D. Average S.D.
Number of comorbidities 17.26 10.38 21.97 11.75 16.24 9.76 ∗∗∗
Note: based on 10,865 and 50,009 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson’s disease who were continuously enrolled in
Medicare Part A and Part B during 2006 and 2007 and were not enrolled in Health Maintenance Organizations during 2006 and 2007; they had a positive
direct total healthcare expenditure; individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to death or some other
reason were excluded from the final sample.
PD: Parkinson’s disease; AA: African American; SUD: substance use disorder; DME: durable medical equipment; HHA: Home Health Agency; SNF: skilled
nursing facility; S.D.: Standard Deviation.
∗∗∗
𝑝 < .001; ∗∗.001 ≤ 𝑝 < .01; ∗.01 ≤ 𝑝 < .05.
characteristics (physical and mental health conditions and
baseline resource use) of the elderly Medicare beneficiaries
explained the highest (approximately 65%) proportion of the
home healthcare use differences between elderly Medicare
beneficiaries with and without PD.
Table 4 also displays the results of linear decomposition
of home healthcare expenditures among elderly Medicare
beneficiaries with and without PD. We restricted these anal-
yses to users of home healthcare. The mean log-transformed
home healthcare expenditure among elderly Medicare ben-
eficiaries with and without PD was 8.44 and 8.09 units,
respectively. This translated into a 0.35-unit difference in
mean log-transformed home healthcare expenditure. Using
pooled regression coefficients, 18% of the home healthcare
expenditures differences among elderly Medicare beneficia-
ries with andwithout PDwere explained, while the remaining
majority (82%) of the home healthcare expenditure differ-
ences remained unexplained. It was observed that baseline
personal health choices explained the highest proportion
of the home healthcare expenditure differences followed by
need factors. Using the pooled weights, it can be inferred that
if the baseline personal health choices were similar between
elderly Medicare beneficiaries with and without PD, then
the home healthcare expenditure would decrease by 12.6%.
Thenegative coefficient of the enabling characteristic signifies
that if the gender, race/ethnicity, and age characteristics of
elderly Medicare beneficiaries with and without PD were
similar, then the difference in home healthcare use would
increase by the respective percentage units.
4. Discussion
The present study examined the magnitude of the difference
in home healthcare resource use and expenditures among
elderly Medicare beneficiaries with and without PD. This
study also evaluated the extent to which predisposing,
enabling, need, personal health choices, and external envi-
ronmental factors explained the differences among elderly
Medicare beneficiaries with and without PD. It was observed
that, after adjusting for the predisposing, need, personal
health choice, and external environmental factors, elderly
Medicare beneficiaries with PD had 13.3% higher home
healthcare use and 39% higher home healthcare expenditures
(among users) compared to those without PD. Previous
studies have consistently found that home healthcare use
and expenditure among individuals with PD are significantly
higher among individuals with PD [1–4]. However, no study
examined the factors associated with higher home healthcare
use and expenditures among elderly individuals with PD
and to what extent the individual-level factors explain such
differences.Theunique contribution of this study is providing
an assessment of the extent to which these individual-level
factors explained the use and expenditure differences using a
nationally representative sample of Medicare beneficiaries.
Approximately 27% and 18% of the home healthcare use
and expenditure differences among elderly Medicare benefi-
ciaries with andwithout PDwere explained by the individual-
level factors adjusted in this study. The need characteristics
such as baseline comorbidities and personal health choices
such as baseline resource use explained the highest pro-
portion of the explained differences. The high unexplained
portions for home healthcare use (72.5%) and expenditure
(82%) difference between elderly Medicare beneficiaries with
and without PD can be due to several factors such as severity
and duration of PD, medication adherence, and inclina-
tion towards seeking healthcare. Moreover, the presence or
absence of a caregiver for elderly Medicare beneficiaries with
PD can also be a contributing factor to the difference.
Findings from this study have profound implications for
healthcare providers, payers, and patients. Findings from the
decomposition analysis identified the factors that contribute
to the excess burden of home healthcare among elderly
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Table 2: Number and percent with home healthcare use and average home healthcare expenditures among users by Parkinson’s disease status
among elderly Medicare beneficiaries. National Medicare 5% sample, 2006-2007.
All
Percent with home healthcare use Average home healthcare expenditures among users
PD No PD Sig. PD No PD Sig.
2,445 22.5 4,601 9.2 ∗∗∗ $6,792 $6,640 $4,965 $5,537
Predisposing characteristics
Gender
Female 1,348 24.9 3,148 10.5 ∗∗∗ $7,055 $198 $5,201 $108 ∗∗∗
Male 1,097 20.2 1,453 7.3 ∗∗∗ $6,469 $227 $4,453 $149 ∗∗∗
Race/ethnicity
White 2,202 22.0 3,933 8.8 ∗∗∗ $6,556 $144 $4,601 $86 ∗∗∗
AA 135 31.8 447 13.7 ∗∗∗ $8,965 $648 $6,639 $312 ∗∗∗
Others 108 24.9 221 10.6 ∗∗∗ $8,904 $1,268 $8,048 $726
Age group
65–74 679 17.3 1,417 5.5 ∗∗∗ $6,545 $288 $4,622 $164 ∗∗∗
75, + 1,766 25.5 3,184 13.2 ∗∗∗ $6,887 $173 $5,117 $103 ∗∗∗
Enabling characteristic
Public assistance
Yes 392 22.5 875 15.3 ∗∗∗ $8,368 $514 $6,785 $286 ∗∗
No 2,053 22.5 3,726 8.4 ∗∗∗ $6,491 $142 $4,537 $84 ∗∗∗
External environmental characteristics
Census regions
Northeastern 562 23.4 996 10.4 ∗∗∗ $5,832 $261 $3,800 $157 ∗∗∗
Midwest 529 18.6 1,010 7.8 ∗∗∗ $5,901 $219 $4,080 $128 ∗∗∗
South 1,031 26.2 1,999 10.3 ∗∗∗ $7,958 $278 $6,120 $162 ∗∗∗
West 323 19.0 596 7.4 ∗∗∗ $6,205 $308 $4,536 $182 ∗∗∗
Metro status
Metro 1,986 23.5 3,584 9.5 ∗∗∗ $6,890 $174 $4,997 $104 ∗∗∗
No metro 459 19.0 1017 8.3 ∗∗∗ $6,372 $270 $4,852 $150 ∗∗∗
Personal health choice
Substance use disorder
Yes 126 28.6 275 14.5 ∗∗∗ $6,385 $544 $5,190 $305 ∗
No 2,319 22.2 4,326 9.0 ∗∗∗ $6,814 $154 $4,950 $91 ∗∗∗
Inpatient visit
Yes 1,141 31.8 1,866 20.1 ∗∗∗ $7,971 $268 $5,699 $165 ∗∗∗
No 1,304 17.9 2,735 6.7 ∗∗∗ $5,761 $160 $4,464 $91 ∗∗∗
DME visit
Yes 1,499 32.0 2,377 16.3 ∗∗∗ $7,766 $236 $5,891 $147 ∗∗∗
No 946 15.3 2,224 6.3 ∗∗∗ $5,250 $143 $3,974 $78 ∗∗∗
Hospice visit
Yes 19 15.6 23 17.2 $6,542 $2,600 $6,286 $1,749
No 2,426 22.6 4,578 9.2 ∗∗∗ $6,794 $149 $4,958 $88 ∗∗∗
SNF visit
Yes 499 31.2 567 28.7 $8,133 $423 $6,314 $290 ∗∗∗
No 1,946 21.0 4,034 8.4 ∗∗∗ $6,449 $158 $4,775 $90 ∗∗∗
Outpatient visit quintile
0-0 313 18.3 809 6.4 ∗∗∗ $6,818 $392 $4,991 $207 ∗∗∗
1-1 303 20.6 668 7.7 ∗∗∗ $7,176 $501 $5,104 $280 ∗∗∗
2-3 514 22.3 972 8.8 ∗∗∗ $6,791 $325 $4,942 $191 ∗∗∗
4–6 545 24.4 860 10.2 ∗∗∗ $6,557 $257 $4,553 $160 ∗∗∗




Percent with home healthcare use Average home healthcare expenditures among users
PD No PD Sig. PD No PD Sig.
2,445 22.5 4,601 9.2 ∗∗∗ $6,792 $6,640 $4,965 $5,537
Office visit quintile
0–5 72 14.3 387 4.3 ∗∗∗ $4,786 $478 $4,134 $189
6–10 206 15.4 630 5.5 ∗∗∗ $5,457 $343 $4,496 $170 ∗∗
11–16 372 17.9 816 7.7 ∗∗∗ $6,037 $308 $4,637 $172 ∗∗∗
17–25 570 21.7 1,048 11.1 ∗∗∗ $6,089 $246 $4,758 $146 ∗∗∗
26 and higher 1,225 28.4 1,720 17.7 ∗∗∗ $7,691 $275 $5,604 $177 ∗∗∗
Need factors
Number of comorbidities
<=16 623 15.4 1,552 5.3 ∗∗∗ $5,649 $195 $4,207 $104 ∗∗∗
>16 1,822 26.8 3,049 14.8 ∗∗∗ $7,183 $1,942 $5,350 $118 ∗∗∗
Note: based on 2,445 and 4,601 elderly (age 65 or older)Medicare beneficiarieswith andwithout Parkinson’s diseasewhowere continuously enrolled inMedicare
Part A and Part B during 2006 and 2007 and were not enrolled in Health Maintenance Organizations during 2006 and 2007; individuals with end-stage renal
disease (ESRD) as well as those without full year enrollments due to death or some other reason were excluded from the final sample. Average home healthcare
expenditures were estimated among users of home healthcare.
S.E.: Standard Errors; PD: Parkinson’s disease; AA: African Americans; DME: durable medical equipment; SNF: skilled nursing facility.
∗∗∗
𝑝 < .001; ∗∗.001 ≤ 𝑝 < .01; ∗.01 ≤ 𝑝 < .05.
Medicare beneficiaries with PD. The study findings can be
useful to the Centers for Medicare and Medicaid Services
(CMS) in formulating programs and policies that can help
reduce home healthcare use and expenditures among elderly
Medicare beneficiaries with PD, thereby having a potential to
bend the ever increasing Medicare cost curve. For example,
the decomposition analyses in this study showed that one
of the major drivers of home healthcare expenditure is the
presence of baseline comorbidities. CMS agency is currently
implementing reimbursement policies that can encourage
management of Medicare beneficiaries with multiple chronic
conditions. The study findings are important for providers as
well as suggesting a need for collaborative care among dif-
ferent specialists such as neurologists, endocrinologists, and
mental health specialists to provide a complete and holistic
care to these elderly individuals with chronic diseases. Our
study findings reinforce the implementation of an integrated
delivery system (IDS) where primary physicians serve as the
gate-keeper and maintain a good referral system, which can
also be helpful in treating elderly individuals with multiple
chronic conditions. In light of the recent Affordable Care Act
(ACA), there is emphasis on team-based approaches such as
Patient Centered Medical Home (PCMH) where continuous
and well-coordinated care is provided by a team of healthcare
providers [19]. The aims of these PCMHs are to provide
evidence based treatments for acute and chronic conditions,
as well as providing preventive services. These types of care
models can be beneficial to the elderly patients as they have
the potential to improve health outcomes, which in turn
can reduce service use and expenditures. Such models can
also reduce the out-of-pocket spending for the patients while
improving their health outcomes.
The study strengths are large sample size, representative
sample, and comprehensive list of variables. While inter-
preting the findings the following limitations need to be
noted. The findings from this study are not generalizable to
other populations or settings. HMO enrollees are excluded
from the study sample. Users of home healthcare may be
different from nonusers of home healthcare in unobserved
variables. Our study does not control for such selection
bias. Five percent Medicare sample did include many vari-
ables that are associated with home healthcare use. This
may lead to underestimation of the explained portion of
the estimated differences in home healthcare expenditures
among individuals with and without PD. However, by using
a representative sample of Medicare beneficiaries with linked
Medicare claims, we were able to estimate the extent to which
unmeasured factors can underestimate explained portion of
the differences in expenditures among individuals with and
without PD.
5. Conclusion
Notwithstanding the limitations, this study examined the
magnitude of the difference in home healthcare resource
use and expenditure among elderly Medicare beneficiaries
with and without PD and also evaluated the extent to which
predisposing, enabling, need, personal health choice, and
external environmental factors explained these differences.
Elderly individuals with PD had 13.3% and 39% higher home
healthcare use and expenditure compared to those without
PD. Individual-level factors used in this study explained
27.5% and 18% of the differences in home healthcare use and
expenditures, respectively. Future studies should compare
the home healthcare use and expenditure among elderly
individuals with PD compared to other neurodegenerative
diseases (e.g., Alzheimer’s disease) and include some of the
factors such as functional status, informal caregiving, severity
of chronic conditions, and medication use, to understand
their influence on the home healthcare use and expenditures.
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Table 3: Adjusted Odds Ratios and 95% Confidence Intervals from logistic regression on home healthcare use and parameter estimates from
OLS regression on log-transformed home healthcare expenditures among users. National Medicare 5% sample, 2006-2007.
AOR 95% CI Sig. Beta S.E. Sig.
Intercept — — — 7.627 0.073 ∗∗∗
Parkinson’s disease








AA 1.52 [1.37, 1.68] ∗∗∗ 0.279 0.043 ∗∗∗
Others 1.13 [0.98, 1.29] 0.170 0.057 ∗∗
Age group








Northeastern 1.29 [1.18, 1.41] ∗∗∗ −0.098 0.040 ∗
Midwest 1.03 [0.94, 1.13] −0.156 0.040 ∗∗∗
South 1.40 [1.29, 1.52] ∗∗∗ 0.196 0.036 ∗∗∗
West
Metro status




Yes 1.11 [0.98, 1.25] −0.004 0.050
No
Outpatient visit quintile
0-0 1.06 [0.96, 1.16] 0.120 0.040 ∗∗
1-1 1.08 [0.99, 1.19] 0.111 0.040 ∗∗
2-3 1.08 [0.99, 1.17] 0.057 0.034
4–6 1.08 [1.00, 1.17] −0.001 0.034
7 or higher
Office visit quintile
0–5 0.87 [0.76, 1.00] −0.071 0.062
6–10 0.87 [0.78, 0.97] ∗ −0.021 0.048
11–16 0.96 [0.87, 1.05] −0.009 0.040
17–25 1.05 [0.97, 1.14] −0.037 0.033
26 or higher
SNF visits 0.88 [0.85, 0.91] ∗∗∗ 0.052 0.012 ∗∗∗
Inpatient visits 1.22 [1.18, 1.26] ∗∗∗ 0.033 0.013 ∗
Hospice visits 0.97 [0.93, 1.01] 0.001 0.016
DME visits 1.05 [1.05, 1.06] ∗∗∗ 0.016 0.002 ∗∗∗
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Table 3: Continued.
AOR 95% CI Sig. Beta S.E. Sig.
Need factors
Number of comorbidities 1.04 [1.03, 1.04] ∗∗∗ 0.006 0.002 ∗∗∗
Note: logistic regression conducted on 10,865 and 50,009 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson’s disease who were
continuously enrolled inMedicare Part A and Part B during 2006 and 2007 and were not enrolled in HealthMaintenance Organizations during 2006 and 2007;
they had a positive direct total healthcare expenditure; individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to
death or some other reason were excluded from the final sample.
Ordinary Least Squares regression conducted on 2,445 and 4,601 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson’s disease who
were continuously enrolled in Medicare Part A and Part B during 2006 and 2007 and were not enrolled in Health Maintenance Organizations during 2006 and
2007; they were home healthcare users; individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to death or some
other reason were excluded from the final sample.
OLS: Ordinary Least Squares; S.E.: Standard Errors; PD: Parkinson’s disease; AA: African Americans; SUD: substance use disorder; DME: durable medical
equipment; SNF: skilled nursing facility.
∗∗∗
𝑝 < .001; ∗∗.001 ≤ 𝑝 < .01; ∗.01 ≤ 𝑝 < .05.
Table 4: Nonlinear and linear decomposition of home healthcare use and expenditures. Elderly Medicare beneficiaries with and without PD.
Medicare 5% claims database (2006, 2007).
% with home healthcare use (PD)




healthcare expenditures (PD) 8.44
Average log-transformed home
healthcare expenditures (no PD) 8.09
Difference 13.3 0.35






Gender, race/ethnicity, age 5.3% 1.8%
Enabling characteristic
Public assistance −1.5% 1.6%
Need characteristic
Number of comorbidities 17.5% 4.1%
Personal health choices
Any type of SUD
Baseline resource use 6.0% 12.6%
External environmental factors
Census region
Metro status 0.2% −2.1%
Explained to total difference 27.5% 18.0%
Unexplained portion 72.5% 82.0%
Note: nonlinear decomposition analysis based on 10,865 and 50,009 elderly (age 65 or older) Medicare beneficiaries with and without PD.
Difference in home healthcare use = 13.3 percentage points. Percentage points in home healthcare use are explained by each independent variable. The
percentage explained is derived by dividing the total explained portion by the 13.3-percentage-point difference between elderly Medicare beneficiaries with
and without PD.
Linear decomposition analysis based on 2,445 and 4,601 elderly (age 65 or older) Medicare beneficiaries with and without PD and who used home healthcare.
SUD: substance use disorder; Exp.: expenditure.
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